News & Updates

Earlier menopause (occurring before age 49) coupled with higher risk of cardiovascular disease (CVD) is associated with an increased risk of cognitive problems later in life, a study suggests.

Patients with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide reported more fatigue, depression and deterioration in perceived cognitive ability, and slower reaction time than those receiving abiraterone acetate, according to results of the ACE study.

Higher abdominal fat, particularly around the pancreas, appears to contribute to lower cognition and brain volumes among middle-aged men at high risk of Alzheimer’s dementia, reports a study. This suggests a possible sex-specific link between distinct abdominal fat and brain health.